General MedicationsINJECTIONGeneric
CLINDAMYCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
Standard Dose
EQ 150MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Discontinued
- Approval overview CLINDAMYCIN PHOSPHATE is listed in Drugs@FDA under application 204749 (ANDA).
- Review priority: STANDARD Marketing status: Discontinued Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 150MG BASE/ML Sponsor RISING Submission history Latest submission status date: 2025-04-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLINDAMYCIN PHOSPHATE is listed in Drugs@FDA under application 204749 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 150MG BASE/ML Sponsor RISING Submission history Latest submission status date: 2025-04-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.